Paediatric ED utilisation in the early phase of the COVID-19 pandemic

Lois Lee1, Rebekah Mannix2, Romain Guedj3

  • 1Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts, USA lois.lee@childrens.harvard.edu.

Insights

Pediatric emergency department (ED) volumes significantly decreased globally during early COVID-19. However, changes in patient acuity and hospital admission rates varied across international children

Area of Science:

  • Global Health
  • Pediatric Emergency Medicine
  • Epidemiology

Background:

  • Previous epidemics like influenza have historically increased pediatric emergency department (ED) patient volumes.
  • The impact of the COVID-19 pandemic on pediatric ED utilization remained uncertain during its initial phase.

Purpose of the Study:

  • To investigate international variations in pediatric ED utilization and patient disposition during the early COVID-19 pandemic.
  • To compare trends across five major children's hospitals in different global locations.

Main Methods:

  • Data on ED volume, patient acuity, and disposition (hospitalization and ICU admission) were collected from December 1, 2017, to August 10, 2020.
  • Utilized paired t-tests or Wilcoxon signed rank tests to analyze percentage changes in ED metrics.
  • Included data from children's hospitals in Boston (USA), Singapore, Melbourne (Australia), Seattle (USA), and Paris (France).

Main Results:

  • A substantial decrease in overall pediatric ED volume was observed across all five hospitals during the early pandemic compared to previous years.
  • Responses in ED volume by acuity level, hospitalization, and intensive care unit (ICU) admission showed variability among the participating hospitals.
  • Paris experienced a notable 2% increase in ICU admissions, an exception to the general trend. By August 2020, ED volumes had increased but remained below pre-pandemic baseline levels.

Conclusions:

  • Pediatric EDs in the studied international locations exhibited varied reductions in patient volume, acuity, and disposition during the initial months of the COVID-19 pandemic.
  • The findings highlight differential impacts of the pandemic on pediatric emergency care across different healthcare systems.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
112
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
138
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
112
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
92
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
289
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
111